Armod
$ 68,00 – $ 255,00Price range: $ 68,00 through $ 255,00
Artane
$ 48,00 – $ 115,00Price range: $ 48,00 through $ 115,00
Aromasin
$ 123,00 – $ 1 152,00Price range: $ 123,00 through $ 1 152,00
Aromasin is an effective aromatase inhibitor primarily used in the treatment of hormone-responsive breast cancer in postmenopausal women. It works by significantly lowering estrogen levels in the body, which helps slow or stop the growth of certain types of breast tumors. This medication is commonly indicated for the adjuvant treatment of estrogen-receptor-positive early breast cancer following two to three years of tamoxifen therapy. It also serves as a vital option for patients with advanced breast cancer whose disease has progressed despite prior hormonal treatments. By targeting the production of estrogen, Aromasin plays a crucial role in reducing the risk of cancer recurrence and managing long-term health outcomes.
Active substance: Exemestane
SKU:
Aromasin
Category: Cancer
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Aromasin belongs to a group of medicines called irreversible steroidal aromatase inhibitors. It is prescribed under medical supervision for specific endocrine-responsive conditions in postmenopausal individuals, functioning by inhibiting the enzymatic conversion of systemic androgens into estrogens.
As a prescription-only drug regulated by the U.S. Food and Drug Administration (FDA), Aromasin is dispensed strictly in accordance with federal and state regulations. Safe administration requires adherence to professional clinical guidelines and routine healthcare monitoring.
| Parameter | Details |
|---|---|
| Drug name | Aromasin |
| Active ingredient (INN) | Exemestane |
| Therapeutic class | Antineoplastic, Irreversible Steroidal Aromatase Inhibitor |
| Dosage form | Oral tablet (25 mg) |
| Route of administration | Oral |
| Prescription status | Prescription only (Rx) |
Clinical Overview and Pharmacology
Main uses
Aromasin is FDA-approved for the adjuvant treatment of postmenopausal women diagnosed with estrogen-receptor positive early breast cancer who have completed 2 to 3 years of tamoxifen therapy and are switched to Aromasin to complete a total of 5 consecutive years of adjuvant hormonal therapy. Additionally, it is indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. Any use of Aromasin outside postmenopausal hormone receptor-positive breast cancer management, such as off-label use for male hormone modulation or body-building protocols, is not FDA-approved and lacks established safety and efficacy parameters.
How the drug works
The mechanism of action of Aromasin relies on its capability to act as a selective, irreversible steroidal aromatase inactivator. In postmenopausal women, circulating estrogen is primarily produced through the conversion of adrenal androgens (androstenedione and testosterone) into estrogens (estrone and estradiol) by the aromatase enzyme in peripheral tissues. Exemestane binds covalently to the active catalytic site of the aromatase enzyme, causing permanent inactivation–a process known as suicide inhibition. Consequently, circulating estrogen levels are suppressed by up to 90%, depriving estrogen-dependent tumor cells of the growth signals required for proliferation.
How it’s absorbed and eliminated
Following oral administration, exemestane is absorbed rapidly from the gastrointestinal tract, achieving peak plasma concentrations within approximately 1.2 hours in postmenopausal patients. Co-administration with a high-fat meal increases the plasma area under the curve (AUC) and maximum plasma concentration by approximately 40%, enhancing overall systemic bioavailability. Exemestane is extensively distributed throughout bodily tissues and is roughly 90% bound to plasma proteins. Metabolism occurs primarily in the liver via the CYP3A4 isoenzyme and aldoreductase pathways. The terminal elimination half-life is approximately 24 hours, with drug metabolites excreted in nearly equal proportions in urine and feces.
Dosing schedule
The standard prescribed dose of Aromasin for adults is one 25 mg tablet taken orally once daily. To ensure optimal systemic absorption, the tablet should be ingested whole with water immediately following a meal. Treatment duration depends on the overall clinical protocol: in adjuvant settings, it is typically taken to complete a total 5-year sequential endocrine regimen following initial tamoxifen therapy. For patients with renal or hepatic impairment, general dosing modifications are not routinely required according to prescribing literature, though close clinical oversight is recommended. Dose adjustments to 50 mg daily may be needed when co-administered with strong metabolic CYP3A4 inducers.
Safety Profile, Precautions, and Q&A
Compatibility with other medicines
Exemestane is metabolized predominantly by the hepatic enzyme CYP3A4. Co-administration of Aromasin with strong CYP3A4 inducers–such as rifampin, phenytoin, carbamazepine, or St. John’s Wort–can significantly decrease plasma concentrations of exemestane, potentially diminishing therapeutic efficacy. In scenarios where strong inducers are clinically mandatory, official guidance advises increasing the Aromasin dose to 50 mg daily. Conversely, estrogen-containing medications, including systemic hormone replacement therapies or hormonal contraceptives, must not be used concurrently, as they directly reverse the pharmacological objective of aromatase inhibition.
What to avoid while taking it
Patients taking Aromasin should avoid concurrent consumption of non-prescription dietary supplements containing St. John’s Wort due to potential CYP3A4 enzyme induction. Furthermore, phytoestrogen-rich preparations or estrogenic herbal products should be avoided to prevent counteracting the estrogen-depriving action of the therapy. Although alcohol does not directly alter the pharmacokinetic clearance of exemestane, excessive alcohol consumption should be avoided because it can accelerate bone mineral density loss and add metabolic burden to the liver. Patients must refrain from transferring this prescription to other individuals.
Adverse reactions
In clinical trials, the adverse event profile of Aromasin was predominantly mild to moderate in severity. The most frequently observed adverse reactions include hot flashes, fatigue, arthralgia (joint pain), musculoskeletal pain, headache, insomnia, hyperhidrosis (increased sweating), and nausea. Because Aromasin significantly suppresses endogenous estrogen, extended administration is associated with a decrease in bone mineral density, elevating the risk of osteopenia, osteoporosis, and skeletal fractures. Clinical evaluations may also occasionally reveal transient elevations in liver transaminases or bilirubin.
Important precautions
Aromasin is indicated exclusively for postmenopausal women and is contraindicated in women who are pregnant, planning to become pregnant, or breastfeeding due to confirmed risk of embryo-fetal toxicity. If menopausal status is clinically uncertain, baseline laboratory verification of LH, FSH, and estradiol levels must be performed prior to therapy initiation. Baseline assessment of bone mineral density (DEXA scan) and serum vitamin D levels should precede treatment, accompanied by periodic monitoring during long-term therapy. Patients with severe hepatic or renal impairment require tailored physician supervision throughout treatment.
Practical tips
To support consistency, Aromasin should be taken at the same time each day, strictly following a meal such as breakfast or dinner. Maintaining adequate daily intake of calcium and vitamin D, paired with weight-bearing exercises as directed by a healthcare provider, can help mitigate treatment-related bone mineral density loss. Compliance with scheduled oncology visits and diagnostic scans is necessary to evaluate therapeutic outcomes. Patients experiencing joint or muscle discomfort should discuss safe analgesic options with their clinician rather than self-administering over-the-counter drugs.
If you skip a dose
If a scheduled dose of Aromasin is missed, it should be taken as soon as remembered on the same day with food. However, if it is nearly time for the next scheduled dose, the missed dose should be omitted and the regular schedule resumed. Patients must not take two doses simultaneously to compensate for a missed tablet. Maintaining steady daily administration helps preserve uniform systemic drug concentrations.
Storage and expiration
Aromasin tablets should be stored at controlled room temperature between 68°F and 77°F (20°C to 25°C), with permitted excursions between 59°F and 86°F (15°C to 30°C) according to standard United States Pharmacopeia (USP) guidelines. Keep the medication in its original container, tightly closed, and protected from excessive moisture and light. Store safely out of reach of children and pets. Expired or unused medication should not be flushed down household drains; utilize designated pharmacy take-back programs for safe disposal.
Common questions
Is Aromasin safe for premenopausal women?
No. Aromasin is not indicated for premenopausal women. In premenopausal individuals with functioning ovaries, aromatase inhibition does not successfully lower systemic estrogen and can induce compensatory gonadotropin secretion, stimulating the ovaries. Menopausal status must be confirmed prior to treatment.
Can Aromasin be stopped abruptly if side effects occur?
Discontinuation of Aromasin should occur only under the direct advice of an oncologist or prescribing physician. Ceasing therapy prematurely may permit estrogen levels to rebound, potentially impacting cancer control objectives. Healthcare providers can provide supportive measures to manage side effects.
Does Aromasin cause weight changes during treatment?
Weight changes, including mild weight gain, have been documented in a subset of patients during clinical investigations. Estrogen suppression can alter fluid balance and body composition. Patients experiencing unexplained or rapid weight gain should consult their physician.
How frequently should bone density be monitored while taking Aromasin?
Bone mineral density is typically assessed prior to starting treatment and monitored periodically–often annually or as clinically indicated by the treating physician. Bone-modifying agents or nutritional supplements may be recommended based on DEXA scan results.
In accordance with FDA requirements, Aromasin is a prescription medication dispensed under regulatory healthcare protocols.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
25mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Arimidex
$ 194,00 – $ 441,00Price range: $ 194,00 through $ 441,00
Active substance: Anastrozole
More Details
This product has multiple variants. The options may be chosen on the product page
Eulexin
$ 51,00 – $ 475,00Price range: $ 51,00 through $ 475,00
Active substance: Flutamide
More Details
This product has multiple variants. The options may be chosen on the product page
Hydrea
$ 64,00 – $ 541,00Price range: $ 64,00 through $ 541,00
Active substance: Hydroxyurea
More Details
This product has multiple variants. The options may be chosen on the product page
Leukeran
$ 60,00 – $ 1 224,00Price range: $ 60,00 through $ 1 224,00
Active substance: Chlorambucil
More Details
This product has multiple variants. The options may be chosen on the product page
Levothroid
$ 42,00 – $ 144,00Price range: $ 42,00 through $ 144,00
Active substance: Levothyroxine sodium
More Details
This product has multiple variants. The options may be chosen on the product page
Purinethol
$ 107,00 – $ 349,00Price range: $ 107,00 through $ 349,00
Active substance: Mercaptopurine
More Details
This product has multiple variants. The options may be chosen on the product page
Synthroid
$ 43,00 – $ 170,00Price range: $ 43,00 through $ 170,00
Active substance: Levothyroxine
More Details
This product has multiple variants. The options may be chosen on the product page
Zofran
$ 44,00 – $ 258,00Price range: $ 44,00 through $ 258,00
Active substance: Ondansetron
More Details
This product has multiple variants. The options may be chosen on the product page
